SWK Holdings Corporation

SWK Holdings Corporation is a publicly traded specialty finance company founded in 1996 and headquartered in Dallas, Texas. It focuses on the healthcare sector, operating in two segments – Finance Receivables and Pharmaceutical Development. The company provides customized financing solutions to a range of life science companies, including biotechnology, medical device, medical diagnostic and related tools, animal health, and pharmaceutical industries, as well as institutions and inventors. It also offers non-discretionary investment advisory services to institutional clients in separately managed accounts to invest in life science finance.

The company’s Pharmaceutical Development business is conducted through its Peptelligence platform. This platform is used to develop, formulate and manufacture pharmaceutical products, as well as license them. The product pipeline of the company includes Ovarest, an oral leuprolide tablet used to treat endocrine disease.

SWK Holdings Corporation is committed to providing innovative financing solutions to its clients and is constantly looking for new opportunities to expand its business. It has a strong presence in the healthcare sector and is dedicated to helping life science companies, institutions and inventors to achieve their goals. The company has an experienced management team and is continuously striving to improve its services and products. It has also been involved in various philanthropic activities, such as supporting the research and development of new treatments for endocrine diseases.